In a significant development on Rare Disease Day, Strand Life Sciences, a subsidiary of Reliance Industries, launched the StrandOmics Portal. This cutting-edge digital platform is crafted to streamline rare disease diagnostics, delivering rapid genetic insights to assist doctors in precise patient evaluations.
About the Author
